Twist Bioscience Corp
Research Twist Bioscience Corp (TWST) on Bullrun: market cap USD 10.01B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTWST
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 10.01B
- Financial periodQ2 2026
- RevenueUSD 118.38M
- Net income-USD 35.05M
- Free cash flow-USD 8.65M
- Gross margin52.8%
Valuation Snapshot
latest market cap is USD 10.01B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 376.57M | -USD 77.67M | -USD 75.63M | 50.7% | -1.3 | USD 183.05M | USD 75.57M | USD 472.96M |
| FY2024 | USD 312.97M | -USD 208.73M | -USD 69.17M | 42.6% | -3.6 | USD 226.32M | USD 85.03M | USD 472.69M |
| FY2023 | USD 245.11M | -USD 204.62M | -USD 170.25M | 36.6% | -3.6 | USD 286.47M | USD 94.07M | USD 623.43M |
| FY2022 | USD 203.57M | -USD 217.86M | -USD 226.24M | 41.4% | -4.04 | USD 378.69M | USD 0 | USD 789.39M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 10.01B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.94B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.77B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.13B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.35B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.93B | n/a | n/a | n/a |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs;
ETFs that hold Twist Bioscience Corp
Twist Bioscience Corp is one of the ten largest holdings of 9 ETFs that investors in Europe can buy. The 8 most traded of them:
| ETF | Weight | TER |
|---|---|---|
| State Street SPDR Russell 2000 US Small Cap UCITS ETF | 0.29% | 0.30% |
| ARK Genomic | 9.98% | 0.75% |
| Global X Genomics & Biotechnology UCITS ETF USD Acc | 6.31% | 0.50% |
| ARK Innovation UCITS ETF Class A USD Accumulation | 4.89% | 0.75% |
| L&G Healthcare Technology & Innovation ETF USD Acc | 3.05% | 0.49% |
| WisdomTree BioRevolution UCITS ETF - USD Acc | 7.21% | 0.45% |
| Global X Telemedicine & Digital Health ETF A | 7.57% | 0.68% |
| State Street SPDR Russell 2000 US Small Cap UCITS ETF EUR Hedged Acc | 0.29% | 0.35% |
Compare every fund on the same index:
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Twist Bioscience Corp's market cap?
Twist Bioscience Corp's market capitalization is USD 10.01B.
What does Twist Bioscience Corp do?
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the.